Session 3 : HER2 Positive Breast Cancer

HER2 Positive Breast Cancer By Sachin Hingmire

Chairpersons :

D C Doval, CJ Tamane

Speaker :

Sachin Hingmire

The effect of trastuzumab-based therapy on overall survival in small, node-negative HER2-positive breast cancer: To treat or not to treat?

Author: Van Ramshorst MS

Conference: SABCS

Prophylactic beta blockage preserves left ventricular ejection fraction in HER2 overexpressing breast cancer patients receiving trastuzumab: Primary results of the MANTICORE randomized controlled trial

Author: Pituskin E

Conference: SABCS